Latest News
Latest News
Is education or screening better for type 1 diabetes?
Despite the impressive data from the FR1DA study, not all diabetes experts are convinced that a general screening for type 1 diabetes would be...
News from the FDA/CDC
FDA OKs empagliflozin for children with type 2 diabetes
This approval represents only the second oral treatment option for children and adolescents with type 2 diabetes after metformin.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
Latest News
Hold Ozempic before surgery to optimize patient safety?
“It’s a really hot issue now. We are getting emails from our members looking for guidance.”
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
Conference Coverage
BMI ‘vastly underestimates’ true obesity
“We’re at the start of the end of BMI.”
Conference Coverage
Anabolic-steroid withdrawal regimens show promise in men
“There is a vacuum of medical advice on what to do” when men stop taking steroids.
Conference Coverage
PCOS associated with shorter lifespan
“I think we need to acknowledge that this is a health burden and not just a reproductive problem.”
Conference Coverage
Big trial reassures on heart safety of testosterone in men
“The community of physicians who prescribe testosterone to men was waiting with bated breath” for the TRAVERSE results.
From the Journals
Depression drives metabolic syndrome
The association between baseline depression and development of metabolic syndrome was strongest for those with severe depression.
Conference Coverage
Vitamin D deficiency: Can we improve diagnosis?
“By measuring total plasma 25(OH)D – as we do right now in clinic – we cannot account for the impact of vitamin D binding proteins, which vary by...